A significantly decrease in specific phobia symptoms was observed, with the severity of specific phobia symptoms decreasing from CSR of 6.10 on average before treatment to a CSR of 1.65 on avarage at the 4 year follow up.
Verulega dró úr alvarleika einkenna fælninnar, meðaltal alvarleika einkenna var 6,10 á CSR fyrir meðferð en fór niður í 1,65 að meðaltali við fjögurra ára eftirfylgni.